FDA Announces New Nationwide Blood Pressure Medication Recall

Live updates

1. 21d ago

   FDA Announces New Nationwide Blood Pressure Medication Recall

   Inventia Healthcare Limited is executing a nationwide recall for 25 mg chlorthalidone tablets due to failed dissolution specifications, which the FDA designated as a Class II recall. The affected medication may not function correctly for patients treating high blood pressure, heart failure, kidney disease, or liver cirrhosis, presenting a moderate risk. Bottles featuring batch number RISA24002 with a March 2027 expiration date are involved. While initial reports cited 13,567 bottles, recent reports indicate the total exceeds 21,000 units. Patients relying on this diuretic must evaluate alternatives to ensure proper therapeutic management of their underlying cardiovascular and renal conditions.

   Why it matters

   Class II recalls indicate that use of the affected product may cause temporary or medically reversible adverse health consequences, or that the likelihood of serious adverse effects is remote. Dissolution failures mean the active ingredient might not release into the body properly, compromising treatment efficacy. This pharmaceutical action highlights ongoing quality control vulnerabilities in generic supply chains.

   What is confirmed

   • Inventia Healthcare Limited is recalling 25 mg chlorthalidone tablets nationwide after the medication failed dissolution specifications.
   • The FDA classified this as a Class II recall.
   • Affected bottles feature batch number RISA24002 and expire in March 2027.

   Still unconfirmed

   • The number of affected units exceeds 21,000 bottles.

   What to watch next

   • Confirmation of the exact final count of affected bottles from Inventia Healthcare or the FDA
   • Updates regarding patient adverse events linked to the dissolved tablet failures
   Sources used for this update (4)

   1. www.yahoo.com — Yahoo
   2. help.naver.com — Futures Flat As Oil Rebounds After Trump's "Energy Ceasefire" Unravels, Memory Stocks Slide | ZeroHedge
   3. www.ntd.com — Lead Sparks Recall of 44,064 Walmart Fruit Cocktails
   4. www.yahoo.com — GLP-1 injections recalled across the US. What to know
   confidence 80%
2. 24d ago

   FDA Class II Recall of Inventia Healthcare Chlorthalidone Tablets

   Inventia Healthcare Limited is recalling 25 mg chlorthalidone tablets nationwide after the medication failed dissolution specifications. The FDA classified this as a Class II recall, meaning the drug poses a moderate risk and may not function correctly for patients treating heart failure, kidney disease, liver cirrhosis, or high blood pressure. Affected bottles feature batch number RISA24002 and expire in March 2027. While initial reports cited 13,567 bottles, recent reports suggest the number of affected units exceeds 21,000.

   Why it matters

   Chlorthalidone is used to manage chronic conditions that require precise dosing to prevent organ failure or cardiovascular events. A failure in dissolution means the drug may not release into the bloodstream at the required rate.

   What is confirmed

   • Inventia Healthcare Limited is conducting a voluntary nationwide recall of 25 mg chlorthalidone tablets.
   • The FDA classified the action as a Class II recall.
   • Affected products bear batch number RISA24002 and an expiration date of March 2027.
   • The medication is used for conditions including high blood pressure, heart failure, kidney disease, and liver cirrhosis.

   Still unconfirmed

   • The medication could contain a superpotent element.
   • More than 21,000 bottles are involved in the recall.

   What to watch next

   • FDA confirmation of the total number of bottles recalled.
   • Official FDA statement regarding the potential for superpotent elements in the medication.
   Sources used for this update (2)

   1. www.thehealthy.com — Blood Pressure Drug Recall: More Than 21,000 Bottles Involved ...
   2. www.fda.gov — CDRH New - News and Updates | FDA
   confidence 80%
3. 27d ago

   FDA Issues Nationwide Recall for Chlorthalidone Blood Pressure Tablets

   Inventia Healthcare Limited is conducting a voluntary nationwide recall of 13,567 bottles of 25 mg chlorthalidone tablets due to failed dissolution specifications. The Food and Drug Administration classified the action as a Class II recall. This indicates the medication carries moderate risk and may fail to work as intended for patients managing conditions such as high blood pressure, heart failure, kidney disease, or liver cirrhosis. Affected products bear batch number RISA24002 and an expiration date of March 2027.

   Why it matters

   Dissolution testing failure means a pharmaceutical product may not release the correct amount of active ingredient into the body at the proper rate, threatening patient stability. Diuretics like chlorthalidone are critical daily treatments for fluid retention and hypertension, making consistent pharmacological potency essential for preventing serious cardiovascular events. Patients dependent on these medications must verify their prescription containers against specific manufacturing details to avoid compromised treatments.

   What is confirmed

   • Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets.
   • The recalled tablets failed dissolution specifications.
   • The Food and Drug Administration classified the action as a Class II recall.
   • Affected medication carries batch number RISA24002 with an expiration date of March 2027.

   What to watch next

   • Further statements from the Food and Drug Administration regarding distribution patterns
   • Instructions from Inventia Healthcare Limited for pharmacy returns
   Sources used for this update (5)

   1. www.fda.gov — Drug Alerts and Statements | FDA
   2. economictimes.indiatimes.com — Terror Attack
   3. www.foxbusiness.com — Great Business Leaders in America & Around the World | Fox Business
   4. www.goodhousekeeping.com — The Best Halloween Movies to Watch Now - Good Housekeeping
   5. www.prevention.com — 59% of People With This Serious Heart Health Risk Don’t Even Know They Have It
   confidence 100%
4. 30d ago

   FDA Expands Blood Pressure Medication Recall

   Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets because the medication failed dissolution specifications. The Food and Drug Administration classified the action as a Class II recall, which signifies moderate risk and indicates that the tablets may fail to work as intended. Affected medication carries batch number RISA24002 with an expiration date of March 2027. Patients who rely on the diuretic for high blood failure, heart failure, kidney disease, or liver cirrhosis must examine their prescription labels immediately.

   Why it matters

   This regulatory action marks the manufacturer's second voluntary recall of chlorthalidone tablets this year. Quality failures involving proper tablet dissolution can prevent patients from receiving their necessary therapeutic doses of blood pressure medication, posing health risks for individuals managing cardiovascular and renal conditions.

   What is confirmed

   • Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets.
   • The FDA classified the recall as Class II, indicating moderate risk.
   • Affected bottles carry batch number RISA24002 and an expiration date of March 2027.
   • This action brings the manufacturer's total recalled bottles of these tablets to 25,027 this year.

   What to watch next

   • Further expansions of the chlorthalidone recall by Inventia Healthcare Limited
   • Additional FDA enforcement reports regarding dissolution failures in diuretic medications
   Sources used for this update (21)

   1. indiawest.com — FDA: Indian Pharma Giants Will Recall Medicines In US Over Quality ...
   2. medivascan.com — Drug recalls, by class and condition - MedivaScan
   3. www.foxbusiness.com — Product Recalls
   4. www.fda.gov — U.S. Food and Drug Administration
   5. www.fda.gov — Drugs | FDA
   6. en.wikipedia.org — Food and Drug Administration - Wikipedia
   7. www.usa.gov — Food and Drug Administration (FDA) | USAGov
   8. www.goodhousekeeping.com — FDA Raises Salad Dressing Recall to Highest Risk Level
   9. drugrecallcheck.com — Check if your medication has been recalled | US Drug Recall ...
   10. medivascan.com — Blood pressure medication recalls | MedivaScan
   11. www.medicaldaily.com — Federal Jury Convicts Michigan Doctor of Distributing More Than 2 Million Stimulant Pills Through Done's ....
   12. www.yahoo.com — Common Blood Pressure Pill Recalled Nationwide - Currently.com
   confidence 100%
5. 39d ago

   FDA Issues Nationwide Recall of 13,567 Chlorthalidone Tablet Bottles

   Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets after they failed dissolution specifications. The FDA classified the recall as Class II, indicating the medication may not work as intended. Affected bottles carry batch number RISA24002 and an expiration date of March 2027. This is the manufacturer's second recall of these tablets this year, bringing the total number of affected bottles to 25,027. Patients using the drug for high blood pressure, heart failure, kidney disease, or liver cirrhosis should verify their labels.

   Why it matters

   Chlorthalidone is used to treat high blood pressure and fluid retention. Failed dissolution means the tablets do not dissolve properly in the body, which can reduce the drug's effectiveness. Patients are cautioned not to stop taking their medication without consulting a provider.

   What is confirmed

   • Inventia Healthcare Limited is recalling 13,567 bottles of 25 mg chlorthalidone tablets.
   • The recall is classified by the FDA as Class II.
   • Affected tablets have batch number RISA24002 and expire in March 2027.
   • The medication failed dissolution testing requirements.
   • This is the second recall for these tablets this year, totaling 25,027 affected bottles.

   Still unconfirmed

   • The FDA is upgrading the recall to a second-highest level.

   What to watch next

   • FDA confirmation of a recall classification upgrade
   • Further batch numbers added to the recall list
   Sources used for this update (16)

   1. www.foxbusiness.com — Health Care
   2. economictimes.indiatimes.com — COVID-19 Vaccine
   3. www.yahoo.com — Blood pressure medication recalled nationwide. See affected drug
   4. flipboard.com — FDA Updates Recalled Blood Pressure Medication to Second-Highest Level
   5. www.iheart.com — Blood Pressure Medication Recalled Nationwide - iHeart
   6. jacksonhealth.org — FDA Announces Nationwide Blood Pressure Medication Recall: Here’s What You Should Know | Jackson Health....
   7. www.newsbeep.com — FDA Announces New Nationwide Blood Pressure Medication Recall
   8. www.medicaldaily.com — Chlorthalidone Blood Pressure Pill Recall Remains Class II, Not Class I, as Patients Check Bottles From L....
   9. www.healthline.com — FDA Issues Class II Blood Pressure Medication Recall, Over 13,000 Bottles Affected
   10. jen.jiji.com — How to stay safe during an attack on a plane
   11. dailyhealthpost.com — Blood Pressure Medication Recalled Nationwide After Failing ...
   12. www.yahoo.com — Check your email: Notices sent regarding $309M Amazon returns settlement
   confidence 95%
6. 45d ago

   FDA Recalls Over 13,000 Bottles of Blood Pressure Medication Nationwide

   The FDA has announced a nationwide recall of over 13,000 bottles of chlorthalidone tablets, used to treat high blood pressure, due to failed dissolution testing. The recall is classified as Class II risk. Patients are advised to check their medication labels to see if their prescription is affected. The affected products failed to meet the agency's dissolution testing requirements.

   Why it matters

   This recall is the latest in a series of actions taken by the FDA to ensure the quality and safety of medications. Chlorthalidone tablets are used to treat hypertension and are commonly prescribed to patients with high blood pressure. The FDA's recall is aimed at preventing potential health risks associated with the affected products.

   What is confirmed

   • Over 13,000 bottles of chlorthalidone tablets are affected by the recall.
   • The recall is due to failed dissolution testing.
   • The FDA classified the recall as Class II risk.
   • Chlorthalidone tablets are used to treat high blood pressure.

   What to watch next

   • Further updates on the recall and potential health risks
   • FDA announcements on additional recalls or safety alerts
   • Patient guidance on checking medication labels and seeking medical advice
   Sources used for this update (11)

   1. AOL.com — FDA Announces New Nationwide Blood Pressure Medication Recall
   2. EatingWell — Blood Pressure Medication Recalled Nationwide—Over 13,000 Bottles Affected
   3. health.com — FDA Announces Recall on Blood Pressure Medication—More Than 13,000 Bottles Affected Nationwide
   4. WHIO TV — Recall alert: 13K bottles of blood pressure medication recalled
   5. SuaraGarut.ID — FDA Classifies Blood Pressure Medication Recall as Class II Risk
   6. economictimes.indiatimes.com — FDA recalls blood pressure medication: Reason, affected drugs, and should you stop taking the pills?
   7. www.yahoo.com — FDA Announces New Nationwide Blood Pressure Medication Recall
   8. www.usatoday.com — Blood pressure medication recalled. See affected product
   9. www.nbcchicago.com — FDA recalls more bottles of blood pressure medication – NBC ...
   10. ground.news — Blood pressure medication recalled nationwide under FDA’s ...
   11. www.yahoo.com — Blood pressure medication recalled nationwide. Check your bottle
   confidence 85%